← All Dossiers
Vicunous – Pre-Round
Funded Vicunous · Pre-Round  ·  SH check $1,176  ·  Post/cap $58,800  ·  Fund: Miles
Dossier generated 2026-07-12 by /deal-dossier  ·  Deal record: recidfJ611IT2VHZs  ·  Source: Airtable appjxAR3LPe3fkHOp

One-Liner & Thesis

An AI-powered holistic aide for small businesses. Vicunous, led by serial founder Osman Kibar (Genoptix, Biosplice), is building a foundation model for funding transactions — starting with friends & family funding for sole proprietorships and expanding into community-bank underwriting and eventually bundling SMB transactions as an institutional asset class.

StoryHouse entered as a symbolic $1,176 common-stock position on the Pre-Round in July 2023, sourced through the Miles fund. On February 17, 2025, Vicunous repurchased StoryHouse's shares in order to avoid a lingering tax liability for LPs as the fund's investment period wound down; the position is now closed. The dossier is retained for reference. The most recent portfolio update (October 1, 2025) shows the team executing on an MVP targeted for mid-November 2025 and staffing up the engineering group.

Investment Score & Recommendation

57/ 100
HOLD

Biggest driver: highly credentialed repeat founder (Kibar) with prior public exit (Genoptix, Novartis). Biggest drag: StoryHouse position has already been repurchased; no ongoing ownership and no follow-on rights in the current round.

Momentum: Steady Red flags: 2 / 9 Confidence: Medium
Market & TAM8/10
25% weight
Team & Founder8/10
25% weight
Product & Traction4/10
20% weight
Deal Terms & Return2/10
20% weight
VC Syndicate5/10
10% weight

Deal

Funding Round
Pre-Round
SH Check
$1,176
Valuation / Post-Cap
$58,800
Date of SH Investment
2023-07-01
Vehicle
Common shares (117,646 shares at $0.01)
Fund
Miles
Status Note
Shares repurchased by Vicunous on 2025-02-17 to close the position ahead of fund investment-period end.

Company Snapshot

Sector
Information Technology
Theme
Enterprise
Location
San Diego, CA
Year Founded
2022
Status
Private

Market Size

$300B
Annual F&F startup funding marketInternal
Founder-cited on 2025-10-01 note
8–10M
New US sole proprietorships / yrInternal
$850B
Total US SMB lending volume 2026Web

Vicunous is aiming at the underserved edge of SMB capital — sole proprietorships raising from friends & family, a segment the founder pegs at $300B/yr with 70% currently routed through credit cards at ~25% APR. Alternative lenders now represent 41% of total SMB lending volume, up from 29% in 2023, so distribution tailwinds are real; whether Vicunous can convert them into a durable, defensible platform is the open question.

Competition

PlayerPositioningFunding / StageEdge vs. them
VicunousAI-native foundation model for funding transactions; F&F loans as MVP wedgePre-Round; total raise undisclosed
Honeycomb CreditRegulated crowdfunded bonds for local SMBsTotal raised $33.2M through March 2026Regulation-CF distribution vs. Vicunous's AI-native underwriting
SMBXReg-CF bond marketplace for Main Street SMBs (up to $5M/yr)$15.2M total raisedRetail-investor bond distribution vs. private F&F workflow
MainvestEquity crowdfunding for brick-and-mortar SMBsShut down (per Honeycomb Credit comparison, 2025)Cautionary comp for the space

Moat: the founder is betting on a proprietary foundation model trained on borrower–investor flow data as the durable moat; incumbents are distribution-first, not model-first.

Traction

Pre-Revenue
LTM RevenueInternal
MVP
Product stageInternal
Targeted mid-Nov 2025 launch (2025-10-01 note)
+3
Engineers addedInternal
Reported 2025-10-01

Exit Potential

Closed
SH PositionInternal
Repurchased 2025-02-17
$1,176
Return on repurchaseInternal
Cost basis returned, no upside participation
n/a
Time to liquidity
Position already closed

StoryHouse's economic exposure to Vicunous ended on 2025-02-17 when the company repurchased the 117,646 common shares for $1,176 (cost basis returned). Repurchase was structured to avoid a downstream tax liability for LPs given the Miles fund's investment-period wind-down. No follow-on rights survived the buyback.

Founders

Osman Kibar
Founder & CEO
Serial technology founder. Founder & Executive Chairman of Biosplice Therapeutics; previously founded Genoptix (oncology diagnostics), which went public on NASDAQ in 2007 and was acquired by Novartis. Also previously started E-tenna, TenaRX and Dynamic Connections.

Open Questions & Risks

Next Steps

Latest Meeting Notes

2025-10-01 Portfolio call MVP targeting F&F sole-prop funding, engineering scaled expand

Portfolio update between Miles and Osman: Vicunous is executing an MVP targeted at friends-&-family funding for sole proprietorships, positioning against $300B/yr of F&F startup capital that currently routes 70% through credit cards at ~25% APR.

Full note

Family update: Kreia (senior year) applying early decision to Pomona; 4.2 GPA, 1560 SAT, three years varsity soccer, switching to cross-country; recently discovered a liberal-arts interest.

Vicunous progress update: leadership approach shifted — Osman stopped seeking consensus and is now making decisions unilaterally. Team reported happier and more efficient; CTO said 'I'm so happy, don't need to think past tomorrow.' Added 3 engineers.

MVP targeting friends & family funding for sole proprietorships. Market framing: $300B annual startup funding market, 70% currently financed via credit cards at 25% interest, 8–10M new sole proprietorships formed annually.

Technical architecture: building a foundation model for funding transactions with owner flow, investor flow, environment flow (as opposed to language/vision/action). Incorporating hierarchical AI with FPGA-style reconfigurability. Data strategy: macro (Bloomberg / public sources), micro (MVP as 'honeypot' collecting borrower data), meso (bundling similar businesses for pattern analysis).

Features in development: budget generator benchmarked against similar businesses; term sheet creation from credit-card alternative; risk-based forced-redemption mechanisms; loan transferability and bundling capabilities.

Next steps: Osman to connect Eric with Miles and Matt for TenRx discussion. Miles to introduce Osman to Freddie Hun (Delos, FICO-score architect for loan-rating expertise), Fred Cummings (Elizabeth Park Capital, largest bank-focused hedge fund), Mike Secuts (BankTech VC, community bank network for distribution). Vicunous MVP release target: mid-November 2025.

Source: Meeting Notes rec82BeeaxT9SRYOM
2024-05-31 Portfolio call Framing Vicunous as an OS for wealth ownership expand

Very brief portfolio note framing Vicunous as an 'operating system for wealth ownership' — ownership expressed as a bundle of rights (possession, disposition, exclusivity, access, enjoyment, control).

Full note

An operating system for wealth ownership. In legalese, ownership = bundle of rights: right of position, disposition, exclusivity, gaining access yourself, enjoyment, right of control.

Source: Meeting Notes recTVdlK3lNJAnIYv
2023-06-15 Portfolio call Recorded call with Osman and Miles expand

Portfolio touchpoint captured only as a link to an Otter.ai transcription of a call between Osman Kibar and Miles; no synthesized notes were logged in Airtable.

Full note

Link to transcription of call with Osman and Miles: (Otter.ai transcript URL logged in Airtable).

Source: Meeting Notes reckDxwc0lIdsM94Q

Deal Timeline

Sources

  1. Nautix Capital — Small Business Lending in 2026 — $850B projected total US SMB lending volume and 41% alt-lender share statistic.
  2. Honeycomb Credit — Comparison vs. Mainvest — Mainvest shutdown reference and Honeycomb Credit / SMBX positioning.
  3. Tracxn — SMBX profile — SMBX $15.2M total-raised figure.
  4. Osman Kibar — LinkedIn — Founder background (Genoptix / Novartis acquisition, Biosplice).